Kim Eun-Ha, Park Su-Jin
Center for Study of Emerging and Re-Emerging Viruses, Korea Virus Research Institute, Institute for Basic Science (IBS), Daejeon 34126, Republic of Korea.
Division of Life Science, Research Institute of Life Science, Gyeongsang National University, Jinju 52828, Republic of Korea.
Microorganisms. 2023 Sep 13;11(9):2309. doi: 10.3390/microorganisms11092309.
Severe Fever with Thrombocytopenia Syndrome (SFTS), caused by (SFTSV), is an emerging infectious disease first identified in China. Since its discovery, infections have spread throughout East Asian countries primarily through tick bites but also via transmission between animals and humans. The expanding range of ticks, the primary vectors for SFTSV, combined with migration patterns of tick-carrying birds, sets the stage for the global spread of this virus. SFTSV rapidly evolves due to continuous mutation and reassortment; currently, no approved vaccines or antiviral drugs are available. Thus, the threat this virus poses to global health is unmistakable. This review consolidates the most recent research on SFTSV, including its molecular characteristics, transmission pathways through ticks and other animals, as well as the progress in antiviral drug and vaccine development, encompassing animal models and clinical trials.
严重发热伴血小板减少综合征(SFTS)由严重发热伴血小板减少综合征病毒(SFTSV)引起,是一种首次在中国发现的新发传染病。自发现以来,感染主要通过蜱虫叮咬在东亚国家传播,但也存在动物与人之间的传播。SFTSV的主要传播媒介蜱虫分布范围不断扩大,再加上携带蜱虫的鸟类的迁徙模式,为这种病毒的全球传播奠定了基础。由于持续的突变和重配,SFTSV迅速进化;目前,尚无获批的疫苗或抗病毒药物。因此,这种病毒对全球健康构成的威胁是显而易见的。本综述整合了关于SFTSV的最新研究,包括其分子特征、通过蜱虫及其他动物的传播途径,以及抗病毒药物和疫苗研发的进展,涵盖动物模型和临床试验。